AI blood test finds silent liver disease years before symptoms

Researchers at the Johns Hopkins Kimmel Cancer Center have developed an artificial intelligence (AI) driven liquid biopsy that analyzes genome wide patterns of cell free DNA (cfDNA) fragments circulating in the blood. The test examines how these DNA pieces break apart and where they appear…

Click here to view the original article.